MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 106 filers reported holding MEI PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -89.2% | 17,707 | -53.7% | 0.00% | – |
| Q4 2021 | $102,000 | +88.9% | 38,278 | +94.6% | 0.00% | – |
| Q3 2021 | $54,000 | -6.9% | 19,666 | -3.9% | 0.00% | – |
| Q2 2021 | $58,000 | +7.4% | 20,472 | +29.9% | 0.00% | -100.0% |
| Q1 2021 | $54,000 | +28.6% | 15,763 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $42,000 | -8.7% | 15,763 | +6.1% | 0.00% | 0.0% |
| Q3 2020 | $46,000 | -27.0% | 14,853 | -2.5% | 0.00% | -33.3% |
| Q2 2020 | $63,000 | +215.0% | 15,234 | +20.9% | 0.00% | – |
| Q1 2020 | $20,000 | -33.3% | 12,597 | +2.5% | 0.00% | -100.0% |
| Q4 2019 | $30,000 | +42.9% | 12,294 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | -32.3% | 12,294 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $31,000 | – | 12,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |